XTANT MEDICAL HOLDINGS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $11.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2019-08-08
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2019-06-30 was -$4.00K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2019-03-31 was $15.00K, a 39373.68% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-12-31 was -$38.00K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2018-09-30 was -$42.00K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2018 was -$121.00K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2017 was -$203.00K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2016 was -$716.74K.
- XTANT MEDICAL HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2015 was -$270.02K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $11.00K 10-Q · filed 2019-08-08 | -$27.00K derived: sum of 3 quarters · filed 2019-08-08 | -$69.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2019-03-31 | $15.00K 10-Q · filed 2019-05-15 | -$23.00K derived: sum of 2 quarters · filed 2019-05-15 | -$65.00K derived: sum of 3 quarters · filed 2019-05-15 | -$106.04K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2018-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$80.00K derived: sum of 2 quarters · filed 2019-04-01 | -$121.04K derived: sum of 3 quarters · filed 2019-04-01 | -$121.00K 10-K · filed 2019-04-01 | |
| 2018-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$83.04K derived: sum of 2 quarters · filed 2018-11-14 | -$83.00K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | -$41.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$41.00K 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | $38.00 10-Q · filed 2018-05-08 | ||||
| 2017-12-31 | -$203.00K 10-K · filed 2019-04-01 | -$202.52K 10-K · filed 2018-04-05 | |||
| 2017-09-30 | -$19.55K 10-Q · filed 2017-11-21 | -$203.38K derived: sum of 2 quarters · filed 2018-03-30 | -$33.35K derived: sum of 3 quarters · filed 2018-03-30 | ||
| 2017-06-30 | -$183.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-30 | -$13.80K 10-Q · filed 2018-03-30 | |||
| 2017-03-31 | $170.03K 10-Q · filed 2018-03-30 | ||||
| 2016-12-31 | -$716.74K 10-K · filed 2018-04-05 | ||||
| 2016-09-30 | $220.41K 10-Q · filed 2016-11-10 | $698.05K derived: sum of 2 quarters · filed 2016-11-10 | $716.74K derived: sum of 3 quarters · filed 2016-11-10 | ||
| 2016-06-30 | $477.64K 10-Q · filed 2016-08-10 | $496.33K 10-Q · filed 2016-11-10 | |||
| 2016-03-31 | $18.69K 10-Q · filed 2016-08-10 | ||||
| 2015-12-31 | -$270.02K 10-K · filed 2017-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |